Advertisement
Screener

NOVAVAX INC (NVAX) Treasury Stock, Common, Value

NOVAVAX INC Treasury Stock, Common, Value

NOVAVAX INC (NVAX) had Treasury Stock, Common, Value of $112.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:TreasuryStockCommonValue · last filed 2026-08-06

  • 2026-06-30: Treasury Stock, Common, Value $112.37M.
  • 2026-03-31: Treasury Stock, Common, Value $112.32M.
  • 2025-12-31: Treasury Stock, Common, Value $103.02M.
  • 2025-09-30: Treasury Stock, Common, Value $102.66M.
Period endTreasury Stock, Common, Value
2026-06-30$112.37M
10-Q · filed 2026-08-06
2026-03-31$112.32M
10-Q · filed 2026-05-06
2025-12-31$103.02M
10-Q · filed 2026-08-06
2025-09-30$102.66M
10-Q · filed 2025-11-06
2025-06-30$102.46M
10-Q · filed 2025-08-06
2025-03-31$101.94M
10-Q · filed 2025-05-08
2024-12-31$95.85M
10-K · filed 2026-02-26
2024-09-30$94.86M
10-Q · filed 2024-11-12
2024-06-30$94.44M
10-Q · filed 2024-08-08
2024-03-31$93.95M
10-Q · filed 2024-05-10
2023-12-31$92.27M
10-K · filed 2025-02-27
2023-09-30$91.71M
10-Q · filed 2023-11-09
2023-06-30$91.42M
10-Q · filed 2023-08-08
2023-03-31$91.23M
10-Q · filed 2023-05-09
2022-12-31$90.66M
10-K · filed 2024-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16